Literature DB >> 10380357

Structural basis of inhibition of cysteine proteases by E-64 and its derivatives.

K Matsumoto1, K Mizoue, K Kitamura, W C Tse, C P Huber, T Ishida.   

Abstract

This paper focuses on the inhibitory mechanism of E-64 and its derivatives (epoxysuccinyl-based inhibitors) with some cysteine proteases, based on the binding modes observed in the x-ray crystal structures of their enzyme-inhibitor complexes. E-64 is a potent irreversible inhibitor against general cysteine proteases, and its binding modes with papain, actinidin, cathepsin L, and cathepsin K have been reviewed at the atomic level. E-64 interacts with the Sn subsites of cysteine proteases. Although the Sn-Pn (n = 1-3) interactions of the inhibitor with the main chains of the active site residues are similar in respective complexes, the significant difference is observed in the side-chain interactions of S2-P2 and S3-P3 pairs because of different residues constituting the respective subsites. E-64-c and CA074 are representative derivatives developed from E-64 as a clinical usable and a cathepsin B-specific inhibitors, respectively. In contrast with similar binding/inhibitory modes of E-64-c and E-64 for cysteine proteases, the inhibitory mechanism of cathepsin B-specific CA074 results from the binding to the Sn' subsite.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10380357     DOI: 10.1002/(SICI)1097-0282(1999)51:1<99::AID-BIP11>3.0.CO;2-R

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  34 in total

Review 1.  Protease pathways in peptide neurotransmission and neurodegenerative diseases.

Authors:  Vivian Y H Hook
Journal:  Cell Mol Neurobiol       Date:  2006-05-25       Impact factor: 5.046

2.  Long-Term Cryopreservation and Revival of Tissue-Engineered Skeletal Muscle.

Authors:  Lauren Grant; Ritu Raman; Caroline Cvetkovic; Meghan C Ferrall-Fairbanks; Gelson J Pagan-Diaz; Pierce Hadley; Eunkyung Ko; Manu O Platt; Rashid Bashir
Journal:  Tissue Eng Part A       Date:  2019-01-09       Impact factor: 3.845

Review 3.  Microbial inhibitors of cysteine proteases.

Authors:  Mateusz Kędzior; Rafał Seredyński; Jan Gutowicz
Journal:  Med Microbiol Immunol       Date:  2016-04-05       Impact factor: 3.402

4.  Inhibition of Amebic Cysteine Proteases Blocks Amebic Trogocytosis but Not Phagocytosis.

Authors:  Allissia A Gilmartin; Katherine S Ralston; William A Petri
Journal:  J Infect Dis       Date:  2020-04-27       Impact factor: 5.226

Review 5.  Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications.

Authors:  Yinan Hua; Sreejayan Nair
Journal:  Biochim Biophys Acta       Date:  2014-05-09

6.  A double-headed cathepsin B inhibitor devoid of warhead.

Authors:  Patricia Schenker; Pietro Alfarano; Peter Kolb; Amedeo Caflisch; Antonio Baici
Journal:  Protein Sci       Date:  2008-09-16       Impact factor: 6.725

7.  Utility of a protein fraction with cathepsin L-Like activity purified from cysticercus fluid of Taenia solium in the diagnosis of human cysticercosis.

Authors:  Mirko Zimic; Mónica Pajuelo; Daniel Rueda; César López; Yanina Arana; Yesenia Castillo; Maritza Calderón; Silvia Rodriguez; Patricia Sheen; Joseph M Vinetz; Armando Gonzales; Héctor H García; Robert H Gilman
Journal:  Am J Trop Med Hyg       Date:  2009-06       Impact factor: 2.345

8.  Structures of human calpain-3 protease core with and without bound inhibitor reveal mechanisms of calpain activation.

Authors:  Qilu Ye; Robert L Campbell; Peter L Davies
Journal:  J Biol Chem       Date:  2018-01-30       Impact factor: 5.157

9.  Kinetic, Mutational, and Structural Studies of the Venezuelan Equine Encephalitis Virus Nonstructural Protein 2 Cysteine Protease.

Authors:  Xin Hu; Jaimee R Compton; Dagmar H Leary; Mark A Olson; Michael S Lee; Jonah Cheung; Wenjuan Ye; Mark Ferrer; Noel Southall; Ajit Jadhav; Elaine M Morazzani; Pamela J Glass; Juan Marugan; Patricia M Legler
Journal:  Biochemistry       Date:  2016-05-19       Impact factor: 3.162

10.  Dynamic Model of Protease State and Inhibitor Trafficking to Predict Protease Activity in Breast Cancer Cells.

Authors:  W Andrew Shockey; Christopher A Kieslich; Catera L Wilder; Valencia Watson; Manu O Platt
Journal:  Cell Mol Bioeng       Date:  2019-06-19       Impact factor: 2.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.